Gene · 8900
Papers2,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reprograming of Gene Expression of Key Inflammatory Signaling Pathways in Human Peripheral Blood Mononuclear Cells by Soybean Lectin and Resveratrol. | Int J Mol Sci | 2022 | 36361735 | PubTator, text mining | PubMed |
| PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism. | Cell Death Dis | 2022 | 36351894 | PubTator, text mining | PubMed |
| Multilevel data integration and molecular docking approach to systematically elucidate the underlying pharmacological mechanisms of Er-Zhi-Wan against hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 36347033 | PubTator, text mining | PubMed |
| SNRPB promotes cell cycle progression in thyroid carcinoma via inhibiting p53. | Open Med (Wars) | 2022 | 36329787 | PubTator, text mining | PubMed |
| Identification of Malignancy in PAP Smear Samples Using the CGB3 and NOP56 Genes as Methylation Markers. | Asian Pac J Cancer Prev | 2022 | 36308381 | PubTator, text mining | PubMed |
| Targeting aldehyde dehydrogenase for prostate cancer therapies. | Front Oncol | 2022 | 36300093 | PubTator, text mining | PubMed |
| Molecular Pathways Related to Sulforaphane as Adjuvant Treatment: A Nanomedicine Perspective in Breast Cancer. | Medicina (Kaunas) | 2022 | 36295538 | PubTator, text mining | PubMed |
| Regulation of Molecular Targets in Osteosarcoma Treatment. | Int J Mol Sci | 2022 | 36293439 | PubTator, text mining | PubMed |
| Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends. | Cancers (Basel) | 2022 | 36291803 | PubTator, text mining | PubMed |
| Comparison of the Medical Uses and Cellular Effects of High and Low Linear Energy Transfer Radiation. | Toxics | 2022 | 36287908 | PubTator, text mining | PubMed |
| A review on the role of cyclin dependent kinases in cancers. | Cancer Cell Int | 2022 | 36266723 | PubTator, text mining | PubMed |
| Prostate cancer induced bone pain: pathobiology, current treatments and pain responses from recent clinical trials. | Discov Oncol | 2022 | 36258057 | PubTator, text mining | PubMed |
| Cyclin genes as potential novel prognostic biomarkers and therapeutic targets in breast cancer. | Oncol Lett | 2022 | 36238849 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Particulate Matter 2.5-Induced Abnormal Effects on Human Sebocytes. | Int J Mol Sci | 2022 | 36232834 | PubTator, text mining | PubMed |
| Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer. | Cancers (Basel) | 2022 | 36230805 | PubTator, text mining | PubMed |
| Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In Vitro. | Cancers (Basel) | 2022 | 36230567 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality. | J Hematol Oncol | 2022 | 36224639 | PubTator, text mining | PubMed |
| T cell receptor dynamic and transcriptional determinants of T cell expansion in glioma-infiltrating T cells. | Neurooncol Adv | 2022 | 36196364 | PubTator, text mining | PubMed |
| Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. | Medicine (Baltimore) | 2022 | 36181052 | PubTator, text mining | PubMed |
| Insight into the pulmonary molecular toxicity of heated tobacco products using human bronchial and alveolar mucosa models at air-liquid interface. | Sci Rep | 2022 | 36180488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8900/papers?page=14